{"disease":{"id":"depressive-disorder-major","name":"depressive disorder major"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03716869","title":"Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":12909,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":true},{"nct_id":"NCT05267873","title":"Combining Data Sources to Identify Effect Moderation for Personalized Mental Health","phase":"","overall_status":"COMPLETED","enrollment_count":9586,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT03832283","title":"Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":4161,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT03165513","title":"Dialogue to Empower Traditional and Faith Healers to Deliver mhGAP-IG Adapted Psychosocial Interventions in Kenya","phase":"NA","overall_status":"COMPLETED","enrollment_count":4081,"lead_sponsor_name":"Africa Institute of Mental and Brain Health (AFRIMEB)","has_results":false},{"nct_id":"NCT02951988","title":"A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1304,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT02845440","title":"Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness","phase":"NA","overall_status":"COMPLETED","enrollment_count":1165,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT05547711","title":"Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":950,"lead_sponsor_name":"Julia Eder","has_results":false},{"nct_id":"NCT05518149","title":"A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":871,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04057378","title":"Optimal Electrical Stimulus During Electroconvulsive Therapy","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Region Örebro County","has_results":false},{"nct_id":"NCT06789822","title":"Detection Algorithm for Recurrence or Relapse of Depression Thanks to a Smartwach","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Dalia Care","has_results":false},{"nct_id":"NCT04513912","title":"A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":757,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06559306","title":"Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":752,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04761757","title":"Antidepressant Decision Aid for Major Depressive Disorder Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":752,"lead_sponsor_name":"University of Malaya","has_results":false},{"nct_id":"NCT05708222","title":"Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)","phase":"","overall_status":"COMPLETED","enrollment_count":715,"lead_sponsor_name":"Medibio Limited","has_results":false},{"nct_id":"NCT02709655","title":"Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":683,"lead_sponsor_name":"H. Lundbeck A/S","has_results":true},{"nct_id":"NCT04338321","title":"A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":676,"lead_sponsor_name":"Janssen-Cilag International NV","has_results":true},{"nct_id":"NCT02871297","title":"Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":662,"lead_sponsor_name":"H. Lundbeck A/S","has_results":true},{"nct_id":"NCT02943564","title":"A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":658,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT02288325","title":"A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT03002077","title":"Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":617,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT04533529","title":"A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":588,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03014544","title":"Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)","phase":"","overall_status":"COMPLETED","enrollment_count":585,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT01138007","title":"A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":572,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05841030","title":"A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":545,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04442490","title":"A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":543,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT02191397","title":"Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":534,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03899168","title":"Confirmation Bias Towards Treatments of Depressive Disorders in Social Tagging","phase":"NA","overall_status":"COMPLETED","enrollment_count":520,"lead_sponsor_name":"Leibniz-Institut für Wissensmedien","has_results":false},{"nct_id":"NCT05455684","title":"A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":513,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT02932943","title":"A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":465,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT05047159","title":"The Role of Neuromodulation Technique In Depression Disorder","phase":"NA","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT05550532","title":"A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":444,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04476030","title":"A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT03560518","title":"Study of Rapastinel as Monotherapy in Patients With MDD","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":439,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT02943577","title":"A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":429,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT04999553","title":"Left vs. Right Non-Inferiority Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":420,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT03113968","title":"ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"Bo Hu","has_results":true},{"nct_id":"NCT04521478","title":"A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":389,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT00048204","title":"A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03614156","title":"Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":363,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT02229825","title":"Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":339,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT02489305","title":"Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)","phase":"","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06793397","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"Cybin IRL Limited","has_results":false},{"nct_id":"NCT00880399","title":"A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":328,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01814098","title":"An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"Xian-Janssen Pharmaceutical Ltd.","has_results":false},{"nct_id":"NCT03207503","title":"Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan","phase":"","overall_status":"COMPLETED","enrollment_count":296,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03227224","title":"A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT05221567","title":"Intensive Psychotherapy for Chronic Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Modum Bad","has_results":false},{"nct_id":"NCT07227454","title":"A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":258,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT02116361","title":"OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05488418","title":"Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56","phase":"NA","overall_status":"UNKNOWN","enrollment_count":255,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}